Total Payments
$13,342
2024 Payments
$1,219
Companies
57
Transactions
859
Medicare Patients
2,024
Medicare Billing
$180,753
Payment Breakdown by Category
Food & Beverage$13,020 (97.6%)
Education$321.60 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,020 | 847 | 97.6% |
| Education | $321.60 | 12 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,812 | 178 | $0 (2024) |
| PFIZER INC. | $1,068 | 91 | $0 (2024) |
| ABBVIE INC. | $892.76 | 70 | $0 (2024) |
| Lilly USA, LLC | $887.44 | 57 | $0 (2024) |
| Allergan, Inc. | $861.40 | 61 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $645.56 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $634.79 | 49 | $0 (2023) |
| Amarin Pharma Inc. | $530.98 | 24 | $0 (2022) |
| GlaxoSmithKline, LLC. | $510.33 | 37 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $485.59 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,219 | 74 | Lilly USA, LLC ($245.98) |
| 2023 | $1,379 | 82 | AbbVie Inc. ($250.67) |
| 2022 | $1,438 | 98 | Novo Nordisk Inc ($177.04) |
| 2021 | $2,051 | 144 | AbbVie Inc. ($445.05) |
| 2020 | $1,810 | 122 | Novo Nordisk Inc ($373.94) |
| 2019 | $1,831 | 136 | Novo Nordisk Inc ($340.85) |
| 2018 | $1,809 | 109 | Novo Nordisk Inc ($766.98) |
| 2017 | $1,805 | 94 | Novo Nordisk Inc ($584.79) |
All Payment Transactions
859 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Oncology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Bone Health | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: Obesity | ||||||
| 09/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardiology | ||||||
| 09/03/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Diabetes | ||||||
| 08/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $4.64 | General |
| 08/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Gastroenterology | ||||||
| 08/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Bone Health | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 480 | 723 | $71,939 | $40,001 |
| 2022 | 18 | 633 | 973 | $102,864 | $57,652 |
| 2021 | 14 | 441 | 792 | $71,550 | $44,408 |
| 2020 | 16 | 470 | 835 | $70,660 | $38,692 |
Total Patients
2,024
Total Services
3,323
Medicare Billing
$180,753
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 129 | 129 | $24,510 | $15,381 | 62.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 147 | $23,520 | $11,847 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 80 | $9,600 | $4,787 | 49.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 34 | 34 | $2,720 | $2,446 | 89.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $2,805 | $1,786 | 63.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 35 | $1,225 | $997.50 | 81.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 21 | 24 | $1,200 | $796.26 | 66.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 85 | $2,975 | $763.68 | 25.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 38 | $1,520 | $616.36 | 40.6% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 23 | 58 | $1,044 | $283.11 | 27.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 24 | 41 | $410.00 | $208.28 | 50.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 41 | $410.00 | $90.20 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 176 | $28,160 | $15,260 | 54.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 115 | 115 | $21,850 | $14,348 | 65.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 90 | $10,800 | $5,627 | 52.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 78 | $7,800 | $4,314 | 55.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 24 | $5,760 | $3,158 | 54.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 18 | $4,968 | $2,682 | 54.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 36 | 36 | $2,880 | $2,467 | 85.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,085 | $1,706 | 41.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $2,805 | $1,603 | 57.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 36 | 37 | $1,850 | $1,294 | 70.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 13 | 15 | $2,175 | $1,215 | 55.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 37 | $1,295 | $1,012 | 78.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 48 | 91 | $3,185 | $952.77 | 29.9% |
About Frank Wang
Frank Wang is a Internal Medicine healthcare provider based in Fairhope, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821286451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frank Wang has received a total of $13,342 in payments from pharmaceutical and medical device companies, with $1,219 received in 2024. These payments were reported across 859 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($13,020).
As a Medicare-enrolled provider, Wang has provided services to 2,024 Medicare beneficiaries, totaling 3,323 services with total Medicare billing of $180,753. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fairhope, AL
- Active Since 10/09/2007
- Last Updated 06/09/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1821286451
Products in Payments
- Ozempic (Drug) $1,057
- Victoza (Drug) $617.54
- VRAYLAR (Drug) $552.08
- XIFAXAN (Drug) $549.49
- XARELTO (Drug) $539.47
- Vascepa (Drug) $530.98
- LEQVIO (Drug) $339.91
- ELIQUIS (Drug) $333.90
- UBRELVY (Drug) $330.18
- TRELEGY ELLIPTA (Drug) $314.75
- TRULICITY (Drug) $307.67
- CHANTIX (Drug) $298.09
- FARXIGA (Drug) $293.50
- MOUNJARO (Drug) $281.87
- JARDIANCE (Drug) $279.29
- Kerendia (Drug) $241.85
- Rybelsus (Drug) $220.75
- EMGALITY (Drug) $207.36
- RYBELSUS (Drug) $205.07
- Cologuard Collection Kit (Device) $202.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fairhope
Erin Bardin, Md, MD
Internal Medicine — Payments: $10,284
Internal Medicine $10,284
Steven Wittmer, Md, MD
Internal Medicine — Payments: $9,498
Internal Medicine $9,498
Bobby Simpson, Do, DO
Internal Medicine — Payments: $7,692
Internal Medicine $7,692
Dr. William Herron, M.d, M.D
Internal Medicine — Payments: $5,508
Internal Medicine $5,508
Jennifer Sykora, M.d, M.D
Internal Medicine — Payments: $5,410
Internal Medicine $5,410
Dr. Richard Snellgrove, Md, MD
Internal Medicine — Payments: $5,128
Internal Medicine $5,128